Wave Life Sciences Reports First Quarter 2021 Financial Results and Provides Business Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
WAVE Life Sciences (WVE) PT Lowered to $6 at Stifel
May 14, 2021 8:47 AM EDTStifel analyst Paul Matteis lowered the price target on WAVE Life Sciences (NASDAQ: WVE) to $6.00 (from $7.00) while maintaining a Hold rating.
The analyst commented, "We are reiterating our Hold rating on Wave after a 1Q21 print that was punctuated by the... More
WAVE Life Sciences (WVE) Misses Q1 EPS by 27c
May 13, 2021 7:34 AM EDTWAVE Life Sciences (NASDAQ: WVE) reported Q1 EPS of ($0.86), $0.27 worse than the analyst estimate of ($0.59).
Despite our PRECISION-HD results at the end of the first quarter, it has been a productive start of the year for Wave and our team remains focused on advancing our clinical trials for... More
